ROSUFIT F 5/160 10S

About

Rosufit F 5/160 is a combination medication containing Rosuvastatin 5 mg and Fenofibrate 160 mg. Rosuvastatin is an HMG-CoA reductase inhibitor (statin) that primarily lowers LDL cholesterol and triglycerides while increasing HDL cholesterol. Fenofibrate is a fibric acid derivative that primarily lowers triglycerides and increases HDL cholesterol, with a moderate effect on LDL cholesterol. This combination targets multiple lipid abnormalities, offering a comprehensive approach to dyslipidemia management.

The synergistic action of Rosuvastatin and Fenofibrate makes this medication particularly effective for patients with mixed dyslipidemia, characterized by elevated LDL cholesterol, high triglycerides, and low HDL cholesterol. It is prescribed when diet and exercise alone are insufficient to control lipid levels, and when treatment with a statin or fibrate alone does not achieve adequate lipid goals. By improving the overall lipid profile, Rosufit F aims to reduce the risk of cardiovascular events in high-risk individuals.

Uses

• Manages mixed dyslipidemia.
• Treats hypertriglyceridemia with low HDL.
• Reduces high cholesterol levels.
• Prevents cardiovascular events in high-risk patients.

Directions For Use

Take this medication orally, once daily, with or without food, as directed by your healthcare provider.

Benefits

• Comprehensive lipid profile improvement.
• Significantly lowers LDL cholesterol and triglycerides.
• Increases beneficial HDL cholesterol.
• Reduces overall cardiovascular risk.
• Effective for complex dyslipidemia.
• Offers dual mechanism of action.

Side Effects

• Muscle pain (myalgia)
• Headache
• Nausea
• Abdominal pain
• Diarrhea
• Constipation
• Elevated liver enzymes
• Pancreatitis (rare)
• Gallstones (cholelithiasis)
• Skin rash
• Fatigue
• Dizziness

Safety Measures

• Alcohol - Concurrent use of alcohol may increase the risk of liver damage and pancreatitis. It is advisable to limit or avoid alcohol consumption.
• Pregnancy - This medication is contraindicated during pregnancy due to potential fetal harm. Women of childbearing potential should use effective contraception.
• Breastfeeding - This medication is contraindicated during breastfeeding as its components may pass into breast milk and harm the infant.
• Liver - Contraindicated in patients with active liver disease or severe hepatic impairment. Regular monitoring of liver function tests is essential.
• Kidney - Contraindicated in patients with severe renal impairment. Dose adjustment or avoidance may be necessary in moderate impairment.
• Lung - No specific contraindications for lung conditions. However, caution is advised in patients with pre-existing respiratory issues.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.